Author: Edison Ong; Mei U Wong; Anthony Huffman; Yongqun He
Title: COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning Document date: 2020_3_21
ID: ld0vo1rl_9
Snippet: The multiple sequence alignment and the resulting phylogeny of nsp3 protein showed that 174 this protein in SARS-CoV-2 was more closely related to the human coronaviruses SARS-CoV and 175 MERS-CoV, and bat coronaviruses BtCoV/HKU3, BtCoV/HKU4, and BtCoV/HKU9. We studied 176 the genetic conservation of nsp3 protein ( Figure 1A (Table S4 -5). In terms of linear B cell epitopes, there were 14 epitopes with BepiPred 195 scores over 0.55 and had at le.....
Document: The multiple sequence alignment and the resulting phylogeny of nsp3 protein showed that 174 this protein in SARS-CoV-2 was more closely related to the human coronaviruses SARS-CoV and 175 MERS-CoV, and bat coronaviruses BtCoV/HKU3, BtCoV/HKU4, and BtCoV/HKU9. We studied 176 the genetic conservation of nsp3 protein ( Figure 1A (Table S4 -5). In terms of linear B cell epitopes, there were 14 epitopes with BepiPred 195 scores over 0.55 and had at least ten amino acids in length (Table S6) (Table 2 ). But the inactivated or attenuated whole virus vaccine might induce strong 218 adverse events. On the other hand, vaccines targeting the structural proteins induce a strong 219 immune response 23,32,33 . In some studies, these structural proteins, including the S and N proteins, 220 were reported to associate with the pathogenesis of coronavirus 24,34 and might raise safety 221 concern 11 . Our study applied state-of-the-art Vaxign reserve vaccinology (RV) and Vaxign-ML 222 only the S protein may induce high serum-neutralizing antibody titers but cannot induce complete 231 protection 10 . In addition, HCoV-NL63 also uses S protein and employs the angiotensin-converting 232 enzyme 2 (ACE2) for cellular entry, despite markedly weak pathogenicity 35 . This suggests that the 233 S protein is not the only factor determining the infection level of a human coronavirus. Thus, 234 alternative vaccine antigens may be considered as potential targets for COVID-19 vaccines. 235
Search related documents:
Co phrase search for related documents- amino acid and art state: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- amino acid and cell epitope: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- amino acid and cellular entry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- amino acid and coronavirus pathogenesis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- amino acid and genetic conservation: 1
- amino acid and human coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- amino acid and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- amino acid and infection level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- amino acid and multiple sequence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
- amino acid and multiple sequence alignment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49
- amino acid and potential target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40
- amino acid and SARS protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82
- amino acid and serum neutralize: 1, 2
- amino acid and structural protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77
- amino acid and vaccine potential target: 1, 2, 3
- amino acid and virus vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65
- angiotensin convert and cellular entry: 1
- angiotensin convert and SARS protein: 1
- antibody titer and art state: 1
Co phrase search for related documents, hyperlinks ordered by date